PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $100 | -100.0% | 9,199 | -93.3% | 0.00% | -100.0% |
| Q3 2022 | $1,155,000 | +273.8% | 137,200 | +793.9% | 0.01% | +500.0% |
| Q4 2020 | $309,000 | -83.6% | 15,349 | -90.2% | 0.00% | -87.5% |
| Q3 2019 | $1,885,000 | -38.3% | 156,961 | -35.4% | 0.01% | -38.5% |
| Q1 2019 | $3,053,000 | +77.0% | 242,862 | -5.2% | 0.01% | +44.4% |
| Q4 2018 | $1,725,000 | -32.9% | 256,220 | +2.6% | 0.01% | -18.2% |
| Q3 2018 | $2,570,000 | +63.5% | 249,704 | +6.8% | 0.01% | +57.1% |
| Q2 2018 | $1,572,000 | +215.7% | 233,830 | +303.3% | 0.01% | +250.0% |
| Q1 2018 | $498,000 | +152.8% | 57,981 | +513.0% | 0.00% | +100.0% |
| Q4 2017 | $197,000 | – | 9,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |